Category: Access campaign
Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is
Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
MSF warns governments are failing to test, treat and prevent TB in children
MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease
MSF’s Mobile Response Team: Bringing mental health support to Kashmir
India: Bringing mental health support to Kashmir
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
